...
首页> 外文期刊>Journal of Analytical Toxicology >Gas chromatographic-mass spectrometric differentiation of atenolol, metoprolol, propranolol, and an interfering metabolite product of metoprolol.
【24h】

Gas chromatographic-mass spectrometric differentiation of atenolol, metoprolol, propranolol, and an interfering metabolite product of metoprolol.

机译:阿替洛尔,美托洛尔,普萘洛尔和美托洛尔的干扰代谢产物的气相色谱-质谱联用法。

获取原文
获取原文并翻译 | 示例
           

摘要

Over a 10-year period, 1993-2002, Federal Aviation Administration identified 50 pilot fatalities involving atenolol, metoprolol, and propranolol, which is consistent with the fact that these drugs have been in the lists of the top 200 drugs prescribed in the U.S. In a few of the 50 pilot fatality cases, initial analysis suggested the presence of atenolol and metoprolol. However, there was no medical history with these cases supporting the use of both drugs. Therefore, atenolol, metoprolol, and/or propranolol, with their possible metabolite(s), were re-extracted from the selected case specimens, derivatized with pentafluoropropionic anhydride (PFPA), and analyzed by gas chromatography-mass spectrometry (GC-MS). The MS spectra of these three antihypertensives and a metoprolol metabolite are nearly identical. All of the PFPA derivatives had baseline GC separation, with the exception of a metoprolol metabolite product, which co-eluted with atenolol. There were four primary mass fragments (m/z 408, 366, 202, and 176) found with all of the PFPA-beta-blockers and with the interfering metabolite product. However, atenolol has three unique fragments (m/z 244, 172, and 132), metoprolol has two unique fragments (m/z 559 and 107), propranolol has four unique fragments (m/z 551, 183, 144, and 127), and the metoprolol metabolite product has two unique fragments (m/z 557 and 149). These distinctive fragments were further validated by using a computer program that predicts logical mass fragments and performing GC-MS of deuterated PFPA-atenolol and PFPA-propranolol and of the PFPA-alpha-hydroxy metabolite of metoprolol. By using the unique mass fragments, none of the pilot fatality cases were found to contain more than one beta-blocker. Therefore, these mass ions can be used for differentiating and simultaneously analyzing these structurally similar beta-blockers in biological samples.
机译:在1993年至2002年的10年中,美国联邦航空管理局确定了50例飞行员死亡,其中涉及阿替洛尔,美托洛尔和普萘洛尔,这与这些药物已被列为美国处方药200强中的事实是一致的。在50例飞行员死亡病例中,有少数病例初步分析表明存在阿替洛尔和美托洛尔。但是,没有医疗史,这些病例均支持两种药物的使用。因此,从选定的病例标本中重新提取出阿替洛尔,美托洛尔和/或普萘洛尔及其可能的代谢产物,用五氟丙酸酐(PFPA)衍生化,并通过气相色谱-质谱(GC-MS)进行分析。这三种降压药和美托洛尔代谢物的MS谱图几乎相同。除美托洛尔代谢产物与阿替洛尔共洗脱外,所有PFPA衍生物均具有基线GC分离。在所有PFPA-β受体阻滞剂和干扰代谢产物中发现了四个主要质量碎片(m / z 408、366、202和176)。但是,阿替洛尔具有三个独特的片段(m / z 244、172和132),美托洛尔具有两个独特的片段(m / z 559和107),普萘洛尔具有四个独特的片段(m / z 551、183、144和127) ),美托洛尔代谢产物具有两个独特的片段(m / z 557和149)。这些独特的片段通过使用预测逻辑质量片段的计算机程序并通过氘化的PFPA-阿替洛尔和PFPA-普萘洛尔以及美托洛尔的PFPA-α-羟基代谢产物的GC-MS进一步验证。通过使用独特的质量碎片,没有发现任何飞行员死亡病例包含超过一种β受体阻滞剂。因此,这些质量离子可用于区分并同时分析生物样品中这些结构相似的β受体阻滞剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号